This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (571)

Published on in Vol 11, No 4 (2022): April

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33517, first published .
Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study

Dexamethasone-Induced Sarcopenia and Physical Frailty in Children With Acute Lymphoblastic Leukemia: Protocol for a Prospective Cohort Study

Authors of this article:

Emma Jacobine Verwaaijen1 Author Orcid Image ;   Annelienke van Hulst1 Author Orcid Image ;   Marta Fiocco1 Author Orcid Image ;   Annelies Hartman2 Author Orcid Image ;   Martha Grootenhuis1 Author Orcid Image ;   Saskia Pluijm1 Author Orcid Image ;   Rob Pieters1 Author Orcid Image ;   Erica van den Akker3 Author Orcid Image ;   Marry M van den Heuvel-Eibrink1 Author Orcid Image
Article Authors Cited by (6) Tweetations (5) Metrics

Journals

  1. Veraldi S, Pietrobattista A, Soglia G, Monti L, Alterio T, Mosca A, Liccardo D, Basso M, Della Corte C, Russo L, Candusso M, Chiusolo F, Tortora F, Spada M, Maggiore G. Sarcopenia in children with chronic liver disease: Prevalence and impact on liver transplant outcomes. Frontiers in Pediatrics 2022;10 View
  2. Verwaaijen E, van Hulst A, Molinger J, Hartman A, Pieters R, Grootenhuis M, van den Akker E, van den Heuvel‐Eibrink M. The utility of a portable muscle ultrasound in the assessment of muscle alterations in children with acute lymphoblastic leukaemia. Journal of Cachexia, Sarcopenia and Muscle 2023;14(5):2216 View
  3. van Hulst A, Verwaaijen E, van den Berg S, van Litsenburg R, Grootenhuis M, Fiocco M, Neggers S, van den Heuvel-Eibrink M, van den Akker E. Leptin Increase During Dexamethasone and Its Association With Hunger and Fat in Pediatric Acute Lymphoblastic Leukemia. The Journal of Clinical Endocrinology & Metabolism 2024;109(3):631 View
  4. Verwaaijen E, van Hulst A, Hartman A, Pieters R, Fiocco M, Pluijm S, van Litsenburg R, Grootenhuis M, van den Akker E, van den Heuvel‐Eibrink M. Physical frailty deteriorates after a 5‐day dexamethasone course in children with acute lymphoblastic leukemia, results of a national prospective study. Cancer Medicine 2023;12(24):22304 View
  5. Lovell A, Gardiner B, Henry L, Bate J, Brougham M, Iniesta R. The evolution of nutritional care in children and young people with acute lymphoblastic leukaemia: a narrative review. Journal of Human Nutrition and Dietetics 2024 View
  6. Li L, van Hulst A, Verwaaijen E, van den Heuvel-Eibrink M, van den Akker E, Rietdijk W, Koch B, Sassen S. Towards optimization of dexamethasone therapy in the maintenance phase of pediatric acute lymphoblastic leukemia: a population pharmacokinetic and pharmacodynamic study of dexamethasone and metabolite. European Journal of Pharmaceutical Sciences 2024:106964 View